Health
Viral ‘molecular scissor’ is next COVID-19 drug target: Coronavirus uses enzymatic cutter for virus production and to disable essential immune proteins – Benzinga
Inhibiting the “scissor” activity of an enzyme of SARS-CoV-2, the coronavirus that causes COVID-19, could be a basis for treatment of the …
Inhibiting the “scissor” activity of an enzyme of SARS-CoV-2, the coronavirus that causes COVID-19, could be a basis for treatment of the infection, researchers at The University of Texas Health Science Center at San Antonio and the Wroclaw University of Science and Technology discovered.
SAN ANTONIO (PRWEB) October 18, 2020
American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design blocking a molecular “scissor” tha…
-
Noosa News22 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General23 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
General18 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz
-
Noosa News11 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland